⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2830205 | 0.94 | — | — | |
| SCHEMBL2828422 | 0.91 | — | — | |
| SCHEMBL7608823 | 0.69 | — | — | |
| SCHEMBL5249613 | 0.62 | — | — | |
| SCHEMBL6057095 | 0.61 | — | — | |
| SCHEMBL4063215 | 0.61 | — | — | |
| SCHEMBL8700399 | 0.61 | — | — | |
| SCHEMBL2198710 | 0.60 | — | — | |
| SCHEMBL545914 | 0.60 | — | — | |
| SCHEMBL6804942 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12258349-B2 | Anti-viral drug | DORING INTERNATIONAL GMBH (CH) | 2025-03-25 | — | — | US | disclosed |
| US-20220298164-A1 | ANTI-VIRAL DRUG | DORING INTERNATIONAL GMBH (CN) | 2022-09-22 | — | — | US | disclosed |
| US-11370797-B2 | Anti-viral drug | DORING INTERNATIONAL GMBH (CH) | 2022-06-28 | — | — | US | disclosed |
| WO-2010151160-A1 | O-SUBSTITUTED 3-N-HETEROARYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL - PORTELA & CA., S.A. (PT) | 2010-12-29 | — | — | WO | disclosed |
| EP-2238131-A1 | 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL - Portela & Ca., S.A. (PT) | 2010-10-13 | — | — | EP | disclosed |
| WO-2009084970-A1 | 5-O-SUBSTITUTED 3-N-PHENYL-1,3,4-OXADIAZOLONES FOR MEDICAL USE | BIAL-PORTELA & COMPANHIA, S.A. (PT) | 2009-07-09 | — | — | WO | disclosed |